8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.
Shield Your Body
Cancer & Tumors

Intermittent ELF-MF exposure effectively ameliorates pathologic features associated with adult AD mice

Bioeffects Seen

Geng D, Liu A, Yan Y, Zheng W · 2025

Share:

Intermittent ELF-MF exposure may be a more effective treatment approach than continuous exposure for AD pathology in adult mice, though the optimal stimulation pattern appears to depend on age and disease progression stage.

Plain English Summary

Summary written for general audiences

This study investigated whether intermittent versus continuous exposure to 40 Hz, 10mT extremely low frequency magnetic fields (ELF-MF) could improve cognitive and neurological outcomes in adult and aged Alzheimer's disease mice. The researchers found that intermittent ELF-MF stimulation was more effective in adult AD mice for improving spatial working memory and enhancing theta/gamma band neural oscillations in the hippocampus, while continuous stimulation showed better results in aged mice, and ELF-MF exposure reduced abnormal accumulation of amyloid-beta and dynamin-related protein markers.

Why This Matters

The study addresses a gap in optimizing ELF-MF therapeutic protocols for AD by systematically comparing exposure modes. The use of multiple outcome measures—behavioral (spatial working memory), electrophysiological (LFPs), and molecular (Aβ42, Drp1)—provides a comprehensive assessment of potential mechanisms, though the abstract appears incomplete at its end.

Exposure Information

Specific exposure levels were not quantified in this study.

Cite This Study
Geng D, Liu A, Yan Y, Zheng W (2025). Intermittent ELF-MF exposure effectively ameliorates pathologic features associated with adult AD mice.
Show BibTeX
@article{geng_d_liu_a_yan_y_zheng_w_ce4379,
  author = {Geng D and Liu A and Yan Y and Zheng W},
  title = {Intermittent ELF-MF exposure effectively ameliorates pathologic features associated with adult AD mice},
  year = {2025},
  doi = {10.1172/JCI182768},
  
}
DOI: 10.1172/JCI182768PubMed: 40544930

Quick Questions About This Study

The study identified three key variants: rs2276868 in the RPL14 gene, rs5361 in SELE, and rs1050462 in HLA-B. The RPL14 variant was most significant, affecting how Epstein-Barr virus behaves in cells and contributing to cancer development.
The RPL14 variant modulates the Epstein-Barr virus life cycle within cells, creating conditions that promote nasopharyngeal carcinoma development. This demonstrates how genetic changes can alter viral behavior and cellular responses in cancer-prone tissues.
EBV infection status mediates the polygenic risk for nasopharyngeal carcinoma. The virus interacts with genetic variants, particularly RPL14, to influence cancer development, showing how infections and genetics work together in cancer formation.
The SELE genetic variant modifies endothelial cell function, which affects blood vessel cells lining tissues. This modification facilitates nasopharyngeal carcinoma progression by altering the tumor microenvironment and cellular communication pathways.
The study developed a refined composite polygenic risk score that outperforms existing models for predicting NPC risk. However, cancer development involves complex interactions between genetics, infections, and environmental factors beyond single genetic tests.